HCPCS Level II code L8688 identifies an implantable, non-rechargeable neurostimulator pulse generator with a dual electrode array and included extension. This device coding matters nationally because it standardizes billing for a high-cost durable medical device used in neuromodulation therapies for chronic pain and certain neurological conditions, affecting coverage determinations and payment flows across commercial and public payers.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how L8688 is classified within HCPCS Level II, the clinical context for use of dual-array non-rechargeable pulse generators, typical sites of service where implantation and replacement occur, and the implications for device billing and claims processing. The publication also outlines common modifiers observed on claims and points readers to where benchmarks and payer-specific policies may affect reimbursement and prior authorization.

This resource is intended to provide procurement, billing, and policy stakeholders with a concise reference to the code, clinical setup, and administrative considerations that influence national billing practices for implantable neurostimulator pulse generators.